Baker Tilly Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Buy |
803
+227
| +39% | +$122K | 0.15% | 139 |
|
|
2025
Q1 | $242K | Buy |
+576
| New | +$242K | 0.09% | 211 |
|
|
2024
Q4 | – | Sell |
-438
| Closed | -$221K | – | 244 |
|
|
2024
Q3 | $221K | Buy |
+438
| New | +$221K | 0.1% | 221 |
|
|
2024
Q2 | – | Sell |
-373
| Closed | -$201K | – | 341 |
|
|
2024
Q1 | $201K | Buy |
+373
| New | +$201K | 0.04% | 407 |
|
|
2023
Q3 | – | Sell |
-1,647
| Closed | -$827K | – | 509 |
|
|
2023
Q2 | $827K | Sell |
1,647
-28
| -2% | -$14.1K | 0.09% | 234 |
|
|
2023
Q1 | $838K | Sell |
1,675
-232
| -12% | -$116K | 0.09% | 230 |
|
|
2022
Q4 | $778K | Buy |
1,907
+466
| +32% | +$190K | 0.1% | 234 |
|
|
2022
Q3 | $469K | Buy |
1,441
+181
| +14% | +$58.9K | 0.06% | 304 |
|
|
2022
Q2 | $442K | Sell |
1,260
-109
| -8% | -$38.2K | 0.06% | 338 |
|
|
2022
Q1 | $749K | Buy |
1,369
+807
| +144% | +$442K | 0.08% | 244 |
|
|
2021
Q4 | $370K | Buy |
562
+77
| +16% | +$50.7K | 0.04% | 403 |
|
|
2021
Q3 | $302K | Buy |
485
+48
| +11% | +$29.9K | 0.04% | 419 |
|
|
2021
Q2 | $276K | Hold |
437
| – | – | 0.04% | 414 |
|
|
2021
Q1 | $214K | Buy |
+437
| New | +$214K | 0.04% | 436 |
|